1,250,473 Shares in Tenet Healthcare Corporation $THC Purchased by Norges Bank

Norges Bank purchased a new stake in Tenet Healthcare Corporation (NYSE:THC) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 1,250,473 shares of the company’s stock, valued at approximately $248,494,000.

Other large investors have also recently added to or reduced their stakes in the company. WCM Investment Management LLC raised its holdings in Tenet Healthcare by 244.4% in the 3rd quarter. WCM Investment Management LLC now owns 510,224 shares of the company’s stock valued at $102,657,000 after acquiring an additional 362,083 shares in the last quarter. Savant Capital LLC raised its holdings in Tenet Healthcare by 27.5% in the 3rd quarter. Savant Capital LLC now owns 16,894 shares of the company’s stock valued at $3,430,000 after acquiring an additional 3,647 shares in the last quarter. Caption Management LLC acquired a new position in Tenet Healthcare in the 3rd quarter valued at approximately $5,650,000. Hillsdale Investment Management Inc. raised its holdings in Tenet Healthcare by 31.0% in the 3rd quarter. Hillsdale Investment Management Inc. now owns 22,800 shares of the company’s stock valued at $4,629,000 after acquiring an additional 5,400 shares in the last quarter. Finally, Eminence Capital LP acquired a new position in Tenet Healthcare in the 3rd quarter valued at approximately $225,263,000. Institutional investors and hedge funds own 95.44% of the company’s stock.

Analysts Set New Price Targets

THC has been the subject of a number of recent research reports. Cantor Fitzgerald reissued an “overweight” rating on shares of Tenet Healthcare in a report on Wednesday, March 4th. Truist Financial increased their target price on Tenet Healthcare from $240.00 to $270.00 and gave the stock a “buy” rating in a report on Tuesday, February 17th. Robert W. Baird dropped their target price on Tenet Healthcare from $245.00 to $210.00 and set a “neutral” rating for the company in a report on Tuesday, May 5th. Weiss Ratings reissued a “buy (b-)” rating on shares of Tenet Healthcare in a report on Friday, March 27th. Finally, UBS Group increased their target price on Tenet Healthcare from $260.00 to $288.00 and gave the stock a “buy” rating in a report on Thursday, February 12th. Nineteen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $244.16.

Insiders Place Their Bets

In other news, Director J Robert Kerrey sold 5,638 shares of Tenet Healthcare stock in a transaction on Thursday, May 28th. The stock was sold at an average price of $174.52, for a total value of $983,943.76. Following the completion of the sale, the director directly owned 16,804 shares of the company’s stock, valued at approximately $2,932,634.08. This trade represents a 25.12% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Paola M. Arbour sold 6,500 shares of the business’s stock in a transaction on Wednesday, March 11th. The stock was sold at an average price of $238.43, for a total value of $1,549,795.00. Following the sale, the executive vice president owned 29,291 shares of the company’s stock, valued at approximately $6,983,853.13. The trade was a 18.16% decrease in their position. The SEC filing for this sale provides additional information. Over the last quarter, insiders sold 23,138 shares of company stock valued at $4,976,589. Company insiders own 0.97% of the company’s stock.

Tenet Healthcare Trading Down 3.4%

THC stock opened at $164.28 on Wednesday. The business has a fifty day moving average price of $189.23 and a 200 day moving average price of $201.72. Tenet Healthcare Corporation has a fifty-two week low of $146.60 and a fifty-two week high of $247.21. The stock has a market capitalization of $14.15 billion, a price-to-earnings ratio of 8.54, a P/E/G ratio of 1.12 and a beta of 1.28. The company has a debt-to-equity ratio of 1.96, a current ratio of 1.36 and a quick ratio of 1.30.

Tenet Healthcare (NYSE:THC) last released its quarterly earnings results on Thursday, April 30th. The company reported $4.82 earnings per share for the quarter, beating analysts’ consensus estimates of $4.21 by $0.61. Tenet Healthcare had a return on equity of 25.55% and a net margin of 7.94%.The firm had revenue of $5.37 billion during the quarter, compared to analysts’ expectations of $5.39 billion. During the same period last year, the firm posted $4.36 EPS. The business’s revenue was up 2.6% on a year-over-year basis. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. Analysts expect that Tenet Healthcare Corporation will post 17.67 EPS for the current fiscal year.

Tenet Healthcare Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.